A team of researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust has developed an artificial pancreas that can benefit patients with both type 2 diabetes (T2D) and kidney failure.
The research team had earlier developed the small, portable system to substitute insulin injections for type 1 diabetes (T1D) patients.
The artificial pancreas can perform the function of a healthy pancreas to maintain blood glucose levels and leverages digital technology for automated insulin delivery.
